Cite
A Phase I and pharmacokinetic study of squalamine, an aminosterol angiogenesis inhibitor.
MLA
Hao, Desirée, et al. “A Phase I and Pharmacokinetic Study of Squalamine, an Aminosterol Angiogenesis Inhibitor.” Clinical Cancer Research : An Official Journal of the American Association for Cancer Research, vol. 9, no. 7, July 2003, pp. 2465–71. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=cmedm&AN=12855619&authtype=sso&custid=ns315887.
APA
Hao, D., Hammond, L. A., Eckhardt, S. G., Patnaik, A., Takimoto, C. H., Schwartz, G. H., Goetz, A. D., Tolcher, A. W., McCreery, H. A., Mamun, K., Williams, J. I., Holroyd, K. J., & Rowinsky, E. K. (2003). A Phase I and pharmacokinetic study of squalamine, an aminosterol angiogenesis inhibitor. Clinical Cancer Research : An Official Journal of the American Association for Cancer Research, 9(7), 2465–2471.
Chicago
Hao, Desirée, Lisa A Hammond, S Gail Eckhardt, Amita Patnaik, Chris H Takimoto, Garry H Schwartz, Andrew D Goetz, et al. 2003. “A Phase I and Pharmacokinetic Study of Squalamine, an Aminosterol Angiogenesis Inhibitor.” Clinical Cancer Research : An Official Journal of the American Association for Cancer Research 9 (7): 2465–71. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=cmedm&AN=12855619&authtype=sso&custid=ns315887.